HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Mycko, M. P. Articles by Hafler, D. A. Search for Related Content PubMed PubMed Citation Articles by Mycko, M. P. Articles by Hafler, D. A.

Cross-Reactive TCR Responses to Self Antigens Presented by Different MHC Class II Molecules

Marcin P. Mycko^1,*, Hanspeter Waldner^*, David E. Anderson^*, Katarzyna D. Bourcier^*, Kai W. Wucherpfennig, Vijay K. Kuchroo^* and David A. Hafler^2,*

^* Center for Neurologic Diseases, Brigham and Women’s Hospital and Harvard Medical School, and Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02115

Autoreactive T cells represent a natural repertoire of T cells in both diseased patients and healthy individuals. The mechanisms regulating the function of these autoreactive T cells are still unknown. Ob1A12 is a myelin basic protein (MBP)-reactive Th cell clone derived from a patient with relapsing-remitting multiple sclerosis. Mice transgenic for this human TCR and DRA and DRB1*1501 chains develop spontaneous experimental autoimmune encephalomyelitis. The reactivity of Ob1A12 is reported to be restricted to recognition of MBP peptide 85–99 in the context of DRB1*1501. DRA/DRB1*1501 and the patient’s other restriction element, DRA/DRB1*0401, differ significantly in their amino acid sequences. In this study we describe an altered peptide ligand derived from MBP_85–99 with a single amino acid substitution at position 88 (Val to Lys; 88VK), that could stimulate the Ob1A12.TCR in the context of both DRA/DRB1*1501 and DRA/DRB1*0401. Analysis of a panel of transfected T cell hybridomas expressing Ob1A12.TCR and CD4 indicated that Ob1A12.TCR cross-reactivity in the context of DRA/DRB1*0401 is critically dependent on the presence of the CD4 coreceptor. Furthermore, we found that activation of Ob1A12.TCR with MBP altered peptide ligand 85–99 88VK presented by DRB1*1501 or DRB1*0401 resulted in significant differences in TCR phosphorylation. Our data indicate that injection of altered peptide ligand into patients heterozygous for MHC class II molecules may result in unexpected cross-reactivities, leading to activation of autoreactive T cells.

This article has been cited by other articles:

				S. Markovic-Plese Degenerate T-Cell Receptor Recognition, Autoreactive Cells, and the Autoimmune Response in Multiple Sclerosis Neuroscientist, June 1, 2009; 15(3): 225 - 231. [Abstract] [PDF]

				M. Sospedra, P. A. Muraro, I. Stefanova, Y. Zhao, K. Chung, Y. Li, M. Giulianotti, R. Simon, R. Mariuzza, C. Pinilla, et al. Redundancy in Antigen-Presenting Function of the HLA-DR and -DQ Molecules in the Multiple Sclerosis-Associated HLA-DR2 Haplotype J. Immunol., February 1, 2006; 176(3): 1951 - 1961. [Abstract] [Full Text] [PDF]

				Z. Karabekian, S. D. Lytton, P. B. Silver, Y. V. Sergeev, J. P. Schneck, and R. R. Caspi Antigen/MHC Class II/Ig Dimers for Study of Uveitogenic T Cells: IRBP p161-180 Presented by both IA and IE Molecules Invest. Ophthalmol. Vis. Sci., October 1, 2005; 46(10): 3769 - 3776. [Abstract] [Full Text] [PDF]